Literature DB >> 21080692

Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors.

Sharangdhar S Phatak1, Edgar A Gatica, Claudio N Cavasotto.   

Abstract

Class A G-protein-coupled receptors (GPCRs) are among the most important targets for drug discovery. However, a large set of experimental structures, essential for a structure-based approach, will likely remain unavailable in the near future. Thus, there is an actual need for modeling tools to characterize satisfactorily at least the binding site of these receptors. Using experimentally solved GPCRs, we have enhanced and validated the ligand-steered homology method through cross-modeling and investigated the performance of the thus generated models in docking-based screening. The ligand-steered modeling method uses information about existing ligands to optimize the binding site by accounting for protein flexibility. We found that our method is able to generate quality models of GPCRs by using one structural template. These models perform better than templates, crude homology models, and random selection in small-scale high-throughput docking. Better quality models typically exhibit higher enrichment in docking exercises. Moreover, they were found to be reliable for selectivity prediction. Our results support the fact that the ligand-steered homology modeling method can successfully characterize pharmacologically relevant sites through a full flexible ligand-flexible receptor procedure.

Mesh:

Substances:

Year:  2010        PMID: 21080692     DOI: 10.1021/ci100285f

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  17 in total

Review 1.  New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi
Journal:  Mol Pharmacol       Date:  2012-06-13       Impact factor: 4.436

Review 2.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Mastering tricyclic ring systems for desirable functional cannabinoid activity.

Authors:  Ravil R Petrov; Lindsay Knight; Shao-Rui Chen; Jim Wager-Miller; Steven W McDaniel; Fanny Diaz; Francis Barth; Hui-Lin Pan; Ken Mackie; Claudio N Cavasotto; Philippe Diaz
Journal:  Eur J Med Chem       Date:  2013-09-29       Impact factor: 6.514

Review 4.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Barkin Berk; Stefano Costanzi
Journal:  J Mol Graph Model       Date:  2011-01-19       Impact factor: 2.518

6.  Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β2 Adrenergic Receptor as a Case Study.

Authors:  Stefano Costanzi; Austin Cohen; Abigail Danfora; Marjan Dolatmoradi
Journal:  J Chem Inf Model       Date:  2019-07-01       Impact factor: 4.956

7.  In silico screening for agonists and blockers of the β(2) adrenergic receptor: implications of inactive and activated state structures.

Authors:  Stefano Costanzi; Santiago Vilar
Journal:  J Comput Chem       Date:  2011-12-14       Impact factor: 3.376

8.  Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.

Authors:  Xingyu Lin; Xi-Ping Huang; Gang Chen; Ryan Whaley; Shiming Peng; Yanli Wang; Guoliang Zhang; Simon X Wang; Shaohui Wang; Bryan L Roth; Niu Huang
Journal:  J Med Chem       Date:  2012-06-19       Impact factor: 7.446

9.  Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs.

Authors:  Anat Levit; Talia Yarnitzky; Ayana Wiener; Rina Meidan; Masha Y Niv
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

10.  Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonists.

Authors:  Peter Kolb; Khai Phan; Zhan-Guo Gao; Adam C Marko; Andrej Sali; Kenneth A Jacobson
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.